[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100557319":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":40,"responsibleParty":57,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":25,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":25,"enrollmentInfo":73,"targetDuration":25,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":25,"overallStatus":83,"whyStopped":25,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University of British Columbia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Sharkskin Group","EXPERIMENTAL","25g Grieshaber Sharkskin ILM Forceps with Reflex Handle",[13],"Device: Internal limiting membrane (ILM) Peeling with Sharkskin Forceps",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard Group","ACTIVE_COMPARATOR","25g Grieshaber standard ILM",[19],"Device: Internal limiting membrane (ILM) Peeling with Standard Forceps",[21,26],{"type":22,"name":23,"description":11,"armGroupLabels":24,"otherNames":25},"DEVICE","Internal limiting membrane (ILM) Peeling with Sharkskin Forceps",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Internal limiting membrane (ILM) Peeling with Standard Forceps","25g Grieshaber Standard ILM Forceps",[15],[31],{"name":32,"affiliation":33,"role":34},"Bryon McKay, MD, PhD","UBC","PRINCIPAL_INVESTIGATOR",[36],{"name":32,"role":37,"phone":38,"phoneExt":25,"email":39},"CONTACT","604 806 9090","mckaybr.phd@gmail.com",[41],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Department of Ophthalmology & Visual Sciences, St Paul's Hospital, Ophthalmology","Vancouver","British Columbia","V6Z 1Y6","Canada","CA",{"type":49,"coordinates":50},"Point",[51,52],-123.11934,49.24966,{"lat":52,"lon":51},[55,56],{"name":32,"role":37,"phone":38,"phoneExt":25,"email":39},{"name":32,"role":34,"phone":25,"phoneExt":25,"email":25},{"type":34,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Bryon McKay","Principal Investigator",[61],{"name":62,"class":63},"Sengi","INDUSTRY","100557319","phase-4-comparison-of-efficacy-between-ilm-forceps-100557319",false,"NCT06536569","Comparison of Efficacy Between ILM Forceps","A Comparison of the Efficacy of 25g Grieshaber Sharkskin ILM Forceps With Reflex Handle vs Standard 25g Grieshaber ILM Forceps for Internal Limiting Membrane Peeling","Inclusion Criteria:\n\n• 19y and older patients with symptomatic ERM (grade 2-3) or Macular hole (non flap-requiring) for elective ILM peeling surgery.\n\nExclusion Criteria:\n\n* Co-morbid diabetic retinopathy of any grade.\n* Neovascular AMD.\n* Previous vitrectomy.\n* Previous retinal detachment treated with scleral buckle or pneumatic retinopexy.\n* Uncontrolled glaucoma or previous glaucoma surgery.\n* Combined phacovitrectomy.\n* Macula holes with severity requiring flap.","ALL","19 Years",{"count":74,"type":75},56,"ESTIMATED","INTERVENTIONAL",[78],"PHASE4","This study is a Single center, prospective, observational, multi surgeon randomized controlled trial. Subjects will be assessed pre-operatively, operatively and at 1 month postoperatively. Clinical evaluations will include measurement of visual acuity and optical coherence tomography (OCT).",[81,82],"Macular Holes","Epiretinal Membrane","NOT_YET_RECRUITING","2025-03-25",{"date":86,"type":87},"2025-03-30","ACTUAL",{"date":89,"type":75},"2025-07-01",{"date":91,"type":75},"2026-01-01",{"name":5,"class":6},1]